Emily Y. Chu

3.8k total citations
91 papers, 2.3k citations indexed

About

Emily Y. Chu is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Emily Y. Chu has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 28 papers in Molecular Biology and 26 papers in Dermatology. Recurrent topics in Emily Y. Chu's work include Cutaneous Melanoma Detection and Management (37 papers), Melanoma and MAPK Pathways (19 papers) and Nonmelanoma Skin Cancer Studies (14 papers). Emily Y. Chu is often cited by papers focused on Cutaneous Melanoma Detection and Management (37 papers), Melanoma and MAPK Pathways (19 papers) and Nonmelanoma Skin Cancer Studies (14 papers). Emily Y. Chu collaborates with scholars based in United States, Australia and Italy. Emily Y. Chu's co-authors include Sarah E. Millar, Thomas Andl, Rosalie Elenitsas, Michael E. Ming, John T. Seykora, Kurt A. Engleka, Deborah Lang, Maozhen Zhang, Min Lü and Li Huang and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Development.

In The Last Decade

Emily Y. Chu

80 papers receiving 2.3k citations

Peers

Emily Y. Chu

ONCOL

DERMA

EPIDE

Lucy Ghali United Kingdom

Mi Ryung Roh South Korea

Sílvia Vanessa Lourenço Brazil

Takashi Saku Japan

J. Schneider Spain

Bernard Czernobilsky Israel

Carlo Cota Italy

Stephen R. Brooks United States

Nanette J. Liégeois United States

Jean‐Christophe Noël Belgium

Lucy Ghali United Kingdom

Emily Y. Chu

854 ×0.7

346 ×0.4

ONCOL

358 ×1.2

DERMA

370 ×1.3

EPIDE

178 ×0.6

Citations per year, relative to Emily Y. Chu Emily Y. Chu (= 1×) peers Lucy Ghali

Countries citing papers authored by Emily Y. Chu

Since Specialization

Citations

This map shows the geographic impact of Emily Y. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Y. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Y. Chu more than expected).

Fields of papers citing papers by Emily Y. Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Y. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Y. Chu. The network helps show where Emily Y. Chu may publish in the future.

Co-authorship network of co-authors of Emily Y. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Y. Chu. A scholar is included among the top collaborators of Emily Y. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Y. Chu. Emily Y. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farooq, Muhammad, et al.. (2025). 0228 Utility of sentinel lymph node biopsy for acral lentiginous melanoma. Journal of Investigative Dermatology. 145(8). S40–S40. 1 indexed citations

Abbott, James, Sarah Ahmed, Melissa Wilson, et al.. (2024). Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants. JAMA Dermatology. 160(11). 1220–1220.

Chu, Emily Y., et al.. (2023). Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings. Human Pathology. 140. 129–143. 2 indexed citations

Stephens, Michael, et al.. (2022). Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies. JAMA Dermatology. 159(2). 215–215. 4 indexed citations

Straker, Richard J., Luke Keele, Emily Y. Chu, et al.. (2022). Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Journal of Surgical Oncology. 126(7). 1263–1271. 3 indexed citations

Straker, Richard J., Adrienne B. Shannon, John T. Miura, et al.. (2021). Acral lentiginous melanoma in the era of immune checkpoint blockade and targeted therapy: A National Cancer Database analysis. Journal of the American Academy of Dermatology. 87(1). 169–172. 4 indexed citations

Straker, Richard J., Nicholas M. Kelly, Adrienne B. Shannon, et al.. (2021). Local recurrence in patients undergoing wide excision and sentinel lymph node biopsy for cutaneous malignant melanoma: A single-center, retrospective cohort analysis. Journal of the American Academy of Dermatology. 87(1). 247–250. 1 indexed citations

Chu, Emily Y., Junko Takeshita, & Michael E. Ming. (2021). Shedding Light on Disparities in Melanoma Care. Journal of Investigative Dermatology. 141(7). 1625–1626.

Chu, Emily Y., et al.. (2020). Challenges in Founding and Developing Medical School Student-Run Asylum Clinics. Journal of Immigrant and Minority Health. 23(1). 179–183. 6 indexed citations

10.

Dentchev, Tzvete, et al.. (2019). Expression of p15 in a spectrum of spitzoid melanocytic neoplasms. Journal of Cutaneous Pathology. 46(5). 310–316. 3 indexed citations

11.

Yun, Sook Jung, Anokhi Jambusaria, Rosalie Elenitsas, et al.. (2018). MART‐1‐labeled melanocyte density and distribution in actinic keratosis and squamous cell cancer in situ: Pagetoid melanocytes are a potential source of misdiagnosis as melanoma in situ. Journal of Cutaneous Pathology. 45(10). 734–742. 6 indexed citations

12.

Sinnamon, Andrew J., et al.. (2018). Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma. JAMA Dermatology. 154(5). 574–574. 16 indexed citations

13.

Sinnamon, Andrew J., Yun Song, Madalyn G. Neuwirth, et al.. (2018). The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex. Journal of the American Academy of Dermatology. 79(2). 245–251. 21 indexed citations

14.

McGettigan, Suzanne, et al.. (2017). Lupus‐like cutaneous reaction following pembrolizumab: An immune‐related adverse event associated with anti‐PD‐1 therapy. Journal of Cutaneous Pathology. 45(1). 74–77. 32 indexed citations

15.

Taylor, Laura A., et al.. (2016). p15 Expression Differentiates Nevus from Melanoma. American Journal Of Pathology. 186(12). 3094–3099. 12 indexed citations

16.

Stewart, Campbell L., Emily Y. Chu, Camille E. Introcaso, András Schaffer, & William D. James. (2013). Coxsackievirus A6–Induced Hand-Foot-Mouth Disease. JAMA Dermatology. 149(12). 1419–1419. 38 indexed citations

17.

Chu, Emily Y., et al.. (2012). In Profile - Tim Jones, MD FRACP. 4(3). 12–16. 1 indexed citations

18.

Chu, Emily Y., Karolyn A. Wanat, Christopher J. Miller, et al.. (2012). Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study. Journal of the American Academy of Dermatology. 67(6). 1265–1272. 128 indexed citations

19.

Liu, Fei, Emily Y. Chu, Brenda Watt, et al.. (2007). Wnt/β-catenin signaling directs multiple stages of tooth morphogenesis. Developmental Biology. 313(1). 210–224. 306 indexed citations

20.

Chu, Emily Y., et al.. (1966). The breast nodule in the full-term infant and in infants born of mothers with diabetes mellitus. The Journal of Pediatrics. 68(6). 983–985. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact